1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Eiko Lifesciences Limited

Eiko Lifesciences Limited

BBSE:EIKO
51.00
INR
+1.89
(+3.85%)
3.82EPS
14.40P/E
724.95MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
4.28
1.85
1.61
1.13
6.52
9.63
- -
27.2
28.22
18.72
27.07
27.64
33.57
42.07
Basic EPS, GAAP
0.37
0.3
0.23
0.49
0.55
-1.01
0.29
1.39
0.78
0.79
0.73
1.62
3.26
3.5
Free Cash Flow per Basic Share
-0.53
-0.8
0.54
-0.98
- -
0.37
1.75
-1.87
-8.57
4.32
-7.25
2.13
1.63
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
8.69
8.72
8.95
9.17
12.62
11.17
16.6
28.42
29.83
30.66
36.56
40.97
47.94
- -
Tangible Book Value per Share
8.69
8.72
8.95
9.17
11.98
10.53
15.95
28.42
29.83
30.66
36.56
40.97
47.94
- -
Basic Weighted Avg Shares
- -
1
3
3
4
4
4
4
9
10
10
13
14
14
Sales/Revenue/Turnover
1
1
6
4
23
42
- -
120
254
183
279
360
463
587
Operating Margin (%)
12.38
24.42
16.89
59.49
11.48
-20.52
- -
3.85
3.19
1.79
3.41
3.05
5.47
11.66
Depreciation Expense
- -
- -
- -
- -
1
2
1
1
6
6
3
7
10
10
Net Income, GAAP
- -
- -
1
2
2
-4
1
6
7
8
8
21
45
49
Effective Tax Rate (%)
30.32
32.18
28.98
24.07
18.4
- -
1.75
26.23
25.08
25.09
23.64
24.35
25.19
25.11
Profit Margin (%)
8.56
16.13
14.28
42.98
8.4
-10.47
- -
5.12
2.77
4.2
2.69
5.84
9.72
8.32
Working Capital
- -
1
5
7
13
1
- -
67
64
81
294
266
320
- -
LT Debt
- -
- -
- -
4
5
4
2
1
1
- -
- -
20
31
- -
Total Equity
2
30
31
32
58
48
55
125
286
294
507
570
698
- -
Return on Invested Capital (%)
4.14
1.06
2.49
4.86
3.93
- -
-9.63
3.39
2.55
0.78
1.81
1.96
2.8
- -
Return on Capital (%)
4.14
1.06
2.49
5.19
4.69
- -
32.06
6.78
4.13
2.81
2.15
3.64
5.83
- -
Return on Common Equity (%)
4.31
1.06
2.6
5.38
4.48
-8.48
2.09
6.19
3.43
2.65
1.88
3.92
7.16
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
17
- -
LT Borrowings
- -
31
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
14
Market Capitalization
755
714
725

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
474
- -
Cash, Cash Equivalents & STI
- -
136
- -
Accounts Receivable, Net
- -
202
- -
Inventories
- -
40
- -
Total Current Liabilities
- -
154
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
17
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
44.77%
47.71%
22.49%
Free Cash Flow
- -
49.73%
-19.07%
Net Income, GAAP
36.9%
63.06%
113.53%
Sales/Revenue/Turnover
- -
38.81%
28.42%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
108
82
75
113
360
2026
107
117
120
183
463
2027
167
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.29
0.22
0.32
0.8
1.62
2026
0.66
0.78
0.88
0.93
3.26
2027
0.91
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Jaid Ismail Kojar
Full Time Employees
3
Sector
Process industries
Industry
Chemicals: specialty
Address
604, Centrum Thane MA India 400 604
IPO Date
Dec 13, 2016
Website
eikolifesciences.com
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
Eiko LifeSciences Ltd. (BSE: EIKO) manufactures, supplies and exports speciality chemicals and pharmaceutical intermediates primarily from its facility in Badlapur, Maharashtra, India. Incorporated in 1977 and headquartered in Thane, Maharashtra, the company offers active pharmaceutical ingredients (APIs), custom synthesis services, agrochemical intermediates, flavour and fragrance chemicals, cosmetic emollients, oleo chemicals and fine chemicals for applications in pharmaceuticals, agrochemicals, personal care, food, aroma chemicals, consumer goods and electronic chemicals; it serves domestic and international markets including Europe. In 2021, the company rebranded from Narendra Investments (Delhi) Limited to focus on chemicals, developed new molecules for agrochemicals, polymers and pharma in 2022, acquired a 25.01% stake in Reflux Pharmaceuticals Private Limited in 2023 to expand into APIs and European markets through co-marketing and raw material supply, and announced diversification into shipping, logistics and comprehensive supply chain services in November 2024.